Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.


20 06, 2010

New Research Study Focuses On Antibodies To Stop Multiple Myeloma

Tags: , |0 Comments

Update on another new anti-myeloma research study, post ASCO:Immunomedics doses first patient in Phase I/II multiple myeloma trialImmunomedics, a biopharmaceutical company, has announced the dosing of the first patient in a Phase I/II clinical trial of the doxorubicin conjugate of milatuzumab for the treatment of patients with relapsed multiple myeloma. The open-label, multi-center Phase I/II